Bio-Techne Corporation
TECH
NASDAQ·Healthcare·Biotechnology·Mkt cap $11.3B
$72.43
▼ -0.03%
P/E
100.60
Mkt Cap
$11.3B
52-Wk Range
$43.20–$72.62
52-Week Range
$43.20 - $72.62
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 36.9% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Comprehensive product portfolio
- Advanced proprietary technologies
- Strong brand reputation in scientific research
- Global distribution network
Bear Case
2 risks
- Average volatility.
- Significant premium - growth priced in
Growth
Stable outlook
Increasing investment in life science research
Value
Significant premium - growth priced in
Momentum
Hot
+36.2% over 3m
Quality
Excellent
Excellent business quality
Dividend
Token
0.44% yield
Smart-money signal
Who's buying TECH right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 4, 2026
AUG 12, 2026
Reported EPS of $0.52 vs $0.52 consensus (+0.2% surprise). Revenue of $321.2M vs $314.6M expected (+2.1%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+0.2%
Revenue trend · last 8Q
—
—
+9%
+4%
+4%
-1%
-0%
+1%
Q4 24
Q1 24
Q2 24
Q3 25
Q4 25
Q1 25
Q2 25
Q4 26
$306.1M
$289.5M
$297.0M
$316.2M
$317.0M
$286.6M
$295.9M
$321.2M
Margins · last 8Q
Gross
65.2%
Operating
22.1%
Profit
17.0%
Wall Street consensus
9 analysts · 11% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
11%
Hold
89%
Sell
0%
Median Price Target
—
Latest: RBC Capital · Jul 9, 2026
vs Industry
How TECH stacks vs Biotechnology
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related